Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Pricing
Go Premium Now
Login
Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Strategies
Tools
Articles
Premium
Advisors
Guaranteed Income

Pills spelling out the word "Big Pharma"

News

The Market Glance for November 6: Big Week for Big Pharma

Asif Imtiaz Nov 06, 2017


After a number of large tech companies added nearly $1 trillion in value to the economy since the start of the year, this week we’re going to see how some of the big names in the pharmaceutical industry fared compared to the tech sector.

Although earnings of healthcare and pharmaceutical companies are not hyped like famous tech companies, we will get to see some large-cap earnings reports from the likes of AstraZeneca PLC (AZN ), Regeneron Pharmaceuticals, Inc. (REGN ) and CVS Health Corporation (CVS ). If your dividend portfolio has exposure to the pharma industry, it might be a good idea to review some of these earnings calls, as they may offer valuable insight into what to expect in the last quarter of the year.

To conclude, in terms of macroeconomic developments, it is going to be a data-light week, but as usual, we will get to see a number of regular weekly updates. Nonetheless, pay special attention to this week’s jobless claims figure as it has gone up since reaching a record low of 222,000 in October.

Check out last week’s Market Glance here in which investors tuned in for Apple’s earnings.

To read the Full Story, Go Premium or Log in

Popular Articles